Development of a New ICT-Based Multisensor Blood Pressure Monitoring System for Use in Hemodynamic Biomarker-Initiated Anticipation Medicine for Cardiovascular Disease: The National IMPACT Program Project
We have developed a multisensor home and ambulatory blood pressure (BP) monitoring system for monitoring 24-hr central and brachial BP variability concurrent with physical activity (PA), temperature, and atmospheric pressure. The new BP monitoring system utilizes our recently developed biological and environmental signal monitoring Information Communication Technology/Internet of Things system, which can simultaneously monitor the environment (temperature, illumination, etc.) of different rooms in a house (entryway, bedroom, living room, bathing room, and toilet), and a wrist-type high-sensitivity actigraph for identifying...
Source: Progress in Cardiovascular Diseases - November 3, 2017 Category: Cardiology Authors: Kazuomi Kario, Naoko Tomitani, Hiroshi Kanegae, Nobuhiko Yasui, Masafumi Nishizawa, Takeshi Fujiwara, Takeya Shigezumi, Ryozo Nagai, Hiroshi Harada Source Type: research

Community-Based Healthy Living Medicine, With a Focus on K-12, Physical Education, and Nutrition
Childhood obesity is one of the country ’s most significant health problems. Researchers estimate that 32.2% of children and adolescents ages 2 to 19 in the United States are overweight and obese. The prevalence of childhood obesity in 2011-2014 was 17.0% and extreme obesity was 5.8% among US children and adolescents aged 2 to 19 years. The high rates of obesity and diabetes, poor nutrition, and lack of physical activity in children and adolescents makes cardiovascular risk reduction in this population critical. (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - November 2, 2017 Category: Cardiology Authors: Sally S. Wong Source Type: research

Table of Contents
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - November 1, 2017 Category: Cardiology Source Type: research

List of Recent Issues
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - November 1, 2017 Category: Cardiology Source Type: research

Editorial Board
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - November 1, 2017 Category: Cardiology Source Type: research

Masthead
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - November 1, 2017 Category: Cardiology Source Type: research

3D Transesophageal Echocardiography: a New Imaging Tool for Assessment of Mitral Regurgitation and for Guiding Percutaneous Edge-to-Edge Mitral Valve Repair
Real time three dimensional transesophageal echocardiography (3D TEE) is probably the most powerful and convincing imaging method for understanding the complicated multiform morphology and for evaluating geometry, dynamics and function of degenerative and functional mitral valve (MV) regurgitation. Moreover, color Doppler 3D TEE has been valuable to identify the location of the regurgitant orifice and the severity of the mitral regurgitation. 3D TEE has been shown to be of enormous value in helping surgeons to perform MV repair. (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - October 19, 2017 Category: Cardiology Authors: Francesco F. Faletra, Alain Berrebi, Giovanni Pedrazzini, Laura Anna Leo, V.L. Paiocch, G. Cautilli, Gabriele Casso, Tiziano Cassina, Tiziano Moccetti, Joseph F. Malouf Source Type: research

Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes
Insulin therapy increased cardiovascular (CV) risk and mortality among type 2 diabetes (T2D) patients in several recently reported clinical outcomes trials. To assess whether this association is causative or coincidental, PubMed searches were used to query the effects of insulin therapy for T2D on CV health and longevity from large-scale outcomes trials, meta-analyses, and patient registry studies, as well as basic research on insulin's direct and pleiotropic actions. Although several old studies provided conflicting results, the majority of large observational studies show strong dose-dependent associations for injected i...
Source: Progress in Cardiovascular Diseases - September 25, 2017 Category: Cardiology Authors: Mary E. Herman, James H. O'Keefe, David S.H. Bell, Stanley S. Schwartz Source Type: research

Insulin Therapy Increases Cardiovascular Risk: Time for a Sea of Change in Type 2 Diabetes Treatment
Insulin therapy increased cardiovascular (CV) risk and mortality among type 2 diabetes (T2D) patients in several recently reported clinical outcomes trials. To assess whether this association is causative or coincidental, PubMed searches were used to query the effects of insulin therapy for T2D on CV health and longevity from large-scale outcomes trials, meta-analyses, and patient registry studies, as well as basic research on insulin ’s direct and pleiotropic actions. Although several old studies provided conflicting results, the majority of large observational studies show strong dose-dependent associations for injecte...
Source: Progress in Cardiovascular Diseases - September 25, 2017 Category: Cardiology Authors: Mary E. Herman, James H. O ’Keefe, David S.H. Bell, Stanley S. Schwartz Source Type: research

Masthead
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - September 1, 2017 Category: Cardiology Source Type: research

Table of Contents
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - September 1, 2017 Category: Cardiology Source Type: research

Editorial Board
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - September 1, 2017 Category: Cardiology Source Type: research

List of Recent Issues
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - September 1, 2017 Category: Cardiology Source Type: research

Approach to Acute Heart Failure in the Emergency Department
Acute heart failure (AHF) patients rarely present complaining of ‘acute heart failure.’ Rather, they initially present to the emergency department (ED) with a myriad of chief complaints, symptoms, and physical exam findings. Such heterogeneity prompts an initially broad differential diagnosis; securing the correct diagnosis can be challenging. Although AHF ma y be the ultimate diagnosis, the precipitant of decompensation must also be sought and addressed. For those AHF patients who present in respiratory or circulatory failure requiring immediate stabilization, treatment begins even while the diagnosis is uncertain. (S...
Source: Progress in Cardiovascular Diseases - August 30, 2017 Category: Cardiology Authors: Benton R. Hunter, Jennifer Martindale, Osama Abdel-Hafez, Peter S. Pang Source Type: research

Pharmacologic Therapy for Heart Failure with Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice
Despite the great progress made in the management of heart failure (HF) with reduced ejection fraction (HFrEF), its prevalence continues to rise owing to an aging population and an epidemic of hypertension, obesity and coronary artery disease. For decades, angiotensin converting enzyme inhibitors and beta blockers have been the mainstay of HFrEF therapy. The recent addition of sacubitril/valsartan and ivabradine to the HF armamentarium has the potential to transform our therapeutic approach to HFrEF, while simultaneously raising some questions and uncertainties on their applicability. (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - August 25, 2017 Category: Cardiology Authors: J. Barr Biglane, Miriam F. Becnel, Hector O. Ventura, Selim R. Krim Source Type: research